Clinical Trial

Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS)

Study acronym: ESUS
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators will measure endothelial glycocalyx, aortic elastic properties, oxidative stress, and their association with left ventricular (LV) and left atrial (LA) function in ESUS, cardioembolic, atherosclerotic, lacunar strokes and age- and sex-adjusted healthy individuals.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-07-24.
Status change: Completed → Active, Not Recruiting 2025-07-10
Trial Details
NCT Number NCT03609437
Lead Sponsor University of Athens
Conditions Embolic Stroke of Undetermined Source, Endothelial Dysfunction
Enrollment 215 participants
Start Date 2018-01-01
Primary Completion 2025-10-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-15